# FDA 483 - Raymond E. Easley, D.O. - May 26, 2023

Source: https://www.keypedia.com/records/483/raymond-e-easley-do/f7679c47-4dcb-4f42-a6ca-fca7b48292af

> FDA 483 for Raymond E. Easley, D.O. on May 26, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Raymond E. Easley, D.O.
- Inspection Date: 2023-05-26
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: Raymond E. Easley, D.O., a clinical research facility in Snellville, GA, was cited with two observations during an FDA inspection. The inspection revealed significant deficiencies in the conduct of a clinical investigation, including the Principal Investigator's failure to adhere to the investigational plan, assess subject eligibility, and provide adequate oversight. Additionally, the firm failed to provide subjects with copies of approved informed consent forms and did not ensure re-consenting with updated versions.

## Related Officers

- [Christopher M. Jeffers](https://www.keypedia.com/people/christopher-m-jeffers/327faaff-619a-4180-ab4c-b5f1b5ba84be)
- [Deborah A. Greco](https://www.keypedia.com/people/deborah-a-greco/38e393b5-55c4-461c-a0b0-4937e0cbec37)

Company: https://www.keypedia.com/companies/raymond-e-easley-do/f643345e-197c-44d8-9344-6fec499eca5b

Office: https://www.keypedia.com/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7